Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen.
AUTOR(ES)
Liu, X F
RESUMO
Four monoclonal antibodies, A35, B94, EB29, and G152, against Marek's disease tumor-associated surface antigen have been developed and their specificities studied against a panel of Marek's disease and lymphoid leukosis primary tumors; Marek's disease, and lymphoid leukosis, and reticuloendotheliosis lymphoblastoid cell lines; and normal chicken cells. A35 and G152 are of the immunoglobulin M class, and B94 and EB29 are of the immunoglobulin G1 subclass.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=264721Documentos Relacionados
- In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.
- Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.
- Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens.
- Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.
- Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.
